OCR Text |
Show Artificial Teeth Never Felt So Natural Before Now... Plastic Cream Discovery Revolutionizes Denture Wearing Forthefirst time science now offers a unique plastic cream that holds your false teeth almostlike Natureherself holds naturalteeth. It forms an elastic membranethat holds both “ mppers’ ” and “lowers” as never before It's Fixopenr-—a revolutionary discovery for daily home use. So different it’s protected by U.S. Patent #3,003; FIXODENT not only holds den- tures firmer, but it holds them more comfortably, too. are)cosernmeyeescla: hel i sl ‘Thus with FrxoDENT you may now eat faster, bite harder. . without pain, You may even enjoy apples, steak, corn-on-the-cob again. FIxopEnt’s special pencil-point dispenser lets you put it exactly F =e< z German Measles whereit’s led. Avoids oozing over and gagging. What's more, FIXODENTresists that can dissolve other adhesives. Just onear lication may last ‘round-the-cloc! Remember, dentures thatfit ae essential to health. see you dentist regularly. Get FINODaNt atall drug counters. ht five-year-old Betty, born hard of hearing and with a heart disorder,has to go to a school Destroys ; Why We Must Win the Race Against for the deaf. With many of her classmates, similarly or otherwise odor on sanitary napkins afflicted, she may be regarded as in the Rubella Class of ’64. Betty is one of the 30,000 surviving youngsters born handicapped after the devastating rubella (German measles) epidemic that swept the nationfive years ago. On the basis of past cycle trends, another widespread outbreak of German measles is expected to strike some time next year. In a dramatic race to forestall the coming epidemic, medical scientists have been rushing to perfect safe and sure-fire antirubella vaccines. Within the next few months, one or more vaccines should receive the necessary go-ahead license from the FederalDivision of Biologics Standards, When that boot3112Sed08 tn.rmYe story of TROY. Sire hove meas’amenprices ‘MASOMSAVINGS now la effect rena red-letter day comes, it will be one of the biggest medical news breaks of the year. it will signal the siart of a mass vac- Helps keep bres and girdles odor-free City ti i ppTT, Cheek refrFREE pt-pt Het. “YOUR CHILD MAY HAVE 1 OUT OF 3 DOES Fidgeting, loss of sleep and a tormenting Tehare often teltaleage of Pin-Worms . ugly par: that ical e:.perts say inet13out of every 3 personsexamined. Entire families maybe victims and not knowit. Toget rid of Pin-Wormas,they must be killed in the large intestine where they live and multiply. That's—— what Jayne's P-W tablets do . here’s how they doit: First—a scientific coating carries the tablets into the bowels before they dissolve. Then—Jayre’s = ern, medicallyapproved ingredient goes right to work—kills Pin-Worms ruil, easily. ek pour pharmacist. cane chances wi pi aeneee: ous,porn contagious“Pin. which infor! entire voter Getpoe genuine see Psmall, eas} take takesaapeeial sizes for dite andadults. You long to ease those pal even temporarily,until the cause iscleared up. palliative, mporary, painreliefFiryDewitt Bie Famous for etic to fuidsthus.‘arin out iitetng pain bladder wastes. raneca often succeed At last—a special deodorantfor you and for your clothes, too—even for sanitary napkins and for pantyhose. It’s QuEsT—the special feminine deodorantfor a woman's very special needs. (1) Quest helps keep your whole body odor-free. So safe it can be used withoutirritating .. . evenin the mostintimate areas. (2) Questhelps prevent odor on clothes as no ordinary deodorant can —underbras, panty-hose,girdies and onsanitary napkins. Works right where embarrassing odorlingers longest! ‘Try Quest today. It’s the special deodorantforyouand yourclothes, too. QuEsT Deodorant. FALSE TEETH Chewing Efficiency Increased up to 35% Cunical teste prove you can now eat and chew better e dentures Sverage up to 35% more eectivenif Dentures that fit ° a Poe Gane ened Doctor samples the blood of mother of vaccinated child in test for contagion. cination of 20 million children, a monumentalproject which is being prepared by the U.S. Departmentof Health, Education, and Welfare. Whatwill this mean to parents, particularly to mothers-to-be? As we all know, this viral disease is usually mild and relatively harmless in children. They get a rash for a few days, fever, some muscular pain, swelling in the neck, end a slight headache. But the infection is contagious, the virus spreading—through the mouth and nose—by close personal contact. The chief danger is to expectant mothers. Whenthe disease hits, especially during the first three months of pregnancy, but 2 Family Weekly, May 4, 1969 also later, the virus can attack the unborn child’s growing organs—the ears, eyes, heart, and brain. One out of four of these babies dies before birth, and as many as half who survive will have one or more birth defects. The infant may be born with cataracts or glaucoma, hepatitis or bone marrow disease, and he may be mentally retarded as well. The 1964 rubella epidemic, the greatest in a generation, affected an estimated 10 million Americans. Nearly 250,000 were pregnant women. According to one study, about 30,000 babies died before birth, and many thousands more succumbed early in infancy. Until now, measures to prevent the damage of rubella have depended largely on therapeutic abortion and gamma globulin immunization, the effectiveness of which is questionable. Inevitably, the ravages of the '64 epidemic spurred anall-out drive for a reliable vaccine. Among those zeroing in on the search were 12 university medical centers, eight pharmaceutical companies, and five industrial-researcl: labs, all coordinated by the National Institutes of Health, While several rubella virus strains have been isolated for study, in the national interest the concentration is mainly on a single virus strain—HPV-77—developed by NIH scientists. (HPV-77 stands for High Passage Virus—77 passages in tissue cultures to grow it.) This is a “live” virus vaccine, considered more effective than a “killed” type. The HPV-77 strain was made available to scientists and drug manufacturers. Vaccines were made up from duck embryotistue culture by Merck & Co. and from dog kidney tissue by Philips Roxane Inc.; another firm, Smith Kline & French, working with an independent rubella strain originating in Belgium, grows its vaccine in rabbit kidney tissues. One university is growingstill another rubella strain in human embryonic lung tissues. The most intensive effort has focused on HPV-77. In testing, scientists at first feared that vaccinated children might transmit the virus to their mothers. That fear has now beenallayed in one mass test after another. In two suburbs of Philadelphia, for example, 265 children received the Merck vaccine. None of their mothers, sisters, or brothers came down with German measies. Among them were i8 pregnant mothers, who showed no sign that they had picked |